Zobrazeno 1 - 10
of 66
pro vyhledávání: '"Kuang-Tai Kuo"'
Autor:
Chi-Tai Yeh, Tzu-Tao Chen, Pamungkas Bagus Satriyo, Chun-Hua Wang, Alexander T. H. Wu, Tsu-Yi Chao, Kang-Yun Lee, Michael Hsiao, Liang-Shun Wang, Kuang-Tai Kuo
Publikováno v:
Oncogenesis, Vol 10, Iss 7, Pp 1-13 (2021)
Abstract Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) are current standard of care for patients with EGFR mutation and metastatic non-small-cell lung carcinoma (NSCLC), but most patients using EGFR TKIs acquire resistance
Externí odkaz:
https://doaj.org/article/06ce9c9834864c0c82dbb26541e4d734
Publikováno v:
International Journal of Infectious Diseases, Vol 114, Iss , Pp 192-194 (2022)
Externí odkaz:
https://doaj.org/article/860670d7ff784d9aad8a5ccde83c1a2d
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 38, Iss 1, Pp 1-17 (2019)
Abstract Background Lung cancer often ranks one of the most prevalent malignancies in the world. One of the most challenging aspects of treating late-stage lung cancer patients is the development of drug resistance, from both conventional chemo- and
Externí odkaz:
https://doaj.org/article/960fc7f1b42c49d082c7d3a5dcc5d818
Autor:
Tung-Yu Tiong, Pei-Wei Weng, Chun-Hua Wang, Syahru Agung Setiawan, Vijesh Kumar Yadav, Narpati Wesa Pikatan, Iat-Hang Fong, Chi-Tai Yeh, Chia-Hung Hsu, Kuang-Tai Kuo
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 13, p 7283 (2022)
Background: Lung cancer remains a leading cause of cancer-related death, with an annual global mortality rate of 18.4%. Despite advances in diagnostic and therapeutic technologies, non–small cell lung carcinoma (NSCLC) continues to be characterized
Externí odkaz:
https://doaj.org/article/9329fff26d0b432c90041dd0e065f94b
Autor:
Kuang-Tai Kuo, Cheng-Hsin Lin, Chun-Hua Wang, Narpati Wesa Pikatan, Vijesh Kumar Yadav, Iat-Hang Fong, Chi-Tai Yeh, Wei-Hwa Lee, Wen-Chien Huang
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 3, p 1663 (2022)
Background: The treatment of non-small-cell lung cancer (NSCLC) involves platinum-based chemotherapy. It is typically accompanied by chemoresistance resulting from antioxidant properties conferred by cancer stem cells (CSCs). Human epidermal growth f
Externí odkaz:
https://doaj.org/article/ceff45ee7ff340db8a56154db01e708a
Autor:
Kuang-Tai Kuo, Wen-Chien Huang, Oluwaseun Adebayo Bamodu, Wei-Hwa Lee, Chun-Hua Wang, M. Hsiao, Liang-Shun Wang, Chi-Tai Yeh
Publikováno v:
Clinical Epigenetics, Vol 10, Iss 1, Pp 1-12 (2018)
Abstract Background Lung cancer is the leading cause of cancer death worldwide. Recently, epigenetic dysregulation has been known to promote tumor progression and therefore may be a therapeutic target for anticancer therapy. JARID1B, a member of hist
Externí odkaz:
https://doaj.org/article/c0553b6b00744a35b3107a665a7a9a26
Autor:
Shin Pai, Vijesh Kumar Yadav, Kuang-Tai Kuo, Narpati Wesa Pikatan, Chun-Shu Lin, Ming-Hsien Chien, Wei-Hwa Lee, Michael Hsiao, Shao-Chih Chiu, Chi-Tai Yeh, Jo-Ting Tsai
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 21, p 11492 (2021)
Background: Oral squamous cell carcinoma (OSCC) has a high prevalence and predicted global mortality rate of 67.1%, necessitating better therapeutic strategies. Moreover, the recurrence and resistance of OSCC after chemo/radioresistance remains a maj
Externí odkaz:
https://doaj.org/article/a1855a558c4e4773ac1ec6099f77d687
Autor:
Yen-Kuang Lin, Chi-Tai Yeh, Kuang-Tai Kuo, Vijesh Kumar Yadav, Iat-Hang Fong, Nicholas G. Kounis, Patrick Hu, Ming-Yow Hung
Publikováno v:
Antioxidants, Vol 10, Iss 8, p 1280 (2021)
Proprotein convertase subtilisin/kexin type 9 (PCSK9) can promote the degradation of low-density lipoprotein (LDL) receptor (LDLR), leading to hypercholesterolemia and myocardial dysfunction. The intracellular regulatory mechanism by which the natura
Externí odkaz:
https://doaj.org/article/b92aaacc0cc24f84b3c6e8f697f8fefb
Autor:
Nen-Chung Chang, Chi-Tai Yeh, Yen-Kuang Lin, Kuang-Tai Kuo, Iat-Hang Fong, Nicholas G. Kounis, Patrick Hu, Ming-Yow Hung
Publikováno v:
Antioxidants, Vol 10, Iss 3, p 461 (2021)
Garcinol, a nicotinic acetylcholine receptor (nAChR) antagonist, has recently been established as an anti-inflammation agent. However, the molecular mechanism by which garcinol suppresses inflammation in the context of acute myocardial infarction (AM
Externí odkaz:
https://doaj.org/article/192207c30a7d4156978def48cb98e805
Autor:
Oluwaseun Adebayo Bamodu, Kuang-Tai Kuo, Chun-Hua Wang, Wen-Chien Huang, Alexander T.H. Wu, Jo-Ting Tsai, Kang-Yun Lee, Chi-Tai Yeh, Liang-Shun Wang
Publikováno v:
Nutrients, Vol 11, Iss 10, p 2264 (2019)
Background: Recently, we demonstrated that Astragalus polysaccharide (PG2), the active ingredient in dried roots of astragalus membranaceus, ameliorates cancer symptom clusters and improves quality of life (QoL) in patients with metastatic disease by
Externí odkaz:
https://doaj.org/article/69887dafdfc74336980e3b3b27db6ae3